Amarin surges as fish-oil drug receives largely positive FDA review

Amarin Corp Plc's fish oil-derived drug received a largely positive review from FDA staffers on Tuesday, dispelling investor fears that the company's choice of placebo in its trial could challenge the approval of its potential blockbuster.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Fish | Fish Oil | Health